Drug Manufacturers - General Industry — Tellvest

Drug Manufacturers - General

Earnings sentiment for Drug Manufacturers - General — aggregated from 9 earnings calls in the Healthcare sector

6.8out of 10Mixed

Aggregated from 9 earnings calls

Industry Sentiment Index

Mixed sentiment across Drug Manufacturers - General

A composite score derived from averaging overall earnings sentiment across all analyzed companies in this industry for their latest reported quarter. Score is 0–10 (10 = most positive).

Sentiment Index

6.8/10-0.2

vs prior Q (same-company basis)

current panel (9 companies)

Companies analyzed

Biggest shifts this quarter

vs Q3 '25 · 9 cos in both

Regulation PolicyImproving

+3cos

0 → 3

Trade & TariffsImproving

-2cos

2 → 0

AI & TechImproving

+1co

1 → 2

Macro Signal Heatmap

Signals mentioned across earnings calls

Improving Stable Mixed Deteriorating

Sort by:

Signal	Companies	Direction breakdown
Regulation Policy	8	341
Trade & Tariffs	4	31
Consumer Demand	4	211

Top Themes

Trending topics in Drug Manufacturers - General

Revenue Growth28Innovation & R&D19Product Launch18Demand15Competitive Dynamics12Guidance Reliability9Regulation Policy7Margin6Pricing6M&A3Cost Pressure3Capital Allocation2

Companies

9 in Drug Manufacturers - General

Company	Sector	Sentiment	Quarter
LLY Lilly (Eli)	Healthcare	9/10	Q4 2025
JNJ Johnson & Johnson	Healthcare	9/10	Q4 2025
AMGN Amgen Inc.	Healthcare	8/10	Q4 2025
ABBV AbbVie	Healthcare	8/10	Q4 2025
GILD Gilead Sciences	Healthcare	7/10	Q4 2025
MRK Merck & Co., Inc.	Healthcare	7/10	Q4 2025
BMY Bristol Myers Squibb	Healthcare	6/10	Q4 2025
PFE Pfizer	Healthcare	4/10	Q4 2025
BIIB Biogen	Healthcare	3/10	Q4 2025